Abstract
Introduction: Managing ARDS is resource-intensive, but published quantitative data are limited.
Objective: To examine the healthcare resource utilization (HRU) and costs of patients hospitalized with ARDS.
Methods: US administrative claims between 2009 and 2013 of commercially-insured individuals and Medicare beneficiaries were analyzed. Patients with ARDS who received mechanical ventilation during the index hospitalization were selected. Each ARDS patient was demographically matched to 10 non-ARDS hospitalized controls. HRU, costs, and comorbidities during one-year prior (baseline), were compared, as were characteristics of the index hospitalization. One-year HRU and costs of a subgroup who were discharged alive and had at least one year follow-up were also examined.
Results: Commercially-insured hospitalized ARDS patients had greater comorbid conditions and prior hospitalizations than matched controls. During the index hospitalization, ARDS patients had longer stays (16.7 vs. 4.6 days), higher mortality (11.9% vs. 0.8%), and incurred higher costs than controls ($117,137 vs. $25,199; all p<0.05). ARDS patients who survived to discharge were more likely to be re-hospitalized (53.2% vs. 12.9%) and incurred higher annual total costs ($82,749 vs. $22,670; both p<0.05) during the subsequent year. Trends were similar for Medicare beneficiaries.
Conclusion: Patients hospitalized with ARDS incurred significantly higher resource utilization and costs than non-ARDS hospitalizations during and prior to the stay. The pattern persists for one year after hospital discharge.
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
[IMG] Abstract Introduction: Managing ARDS is...
-
- There are more pages in this discussion • 16,031 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.8¢ |
Change
0.003(0.27%) |
Mkt cap ! $1.059B |
Open | High | Low | Value | Volume |
94.0¢ | 94.0¢ | 92.5¢ | $840.8K | 902.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 313851 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 123553 | 39 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 320655 | 0.925 |
30 | 173168 | 0.920 |
15 | 200126 | 0.915 |
10 | 226049 | 0.910 |
5 | 33181 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
0.930 | 129774 | 40 |
0.935 | 73081 | 12 |
0.940 | 104620 | 13 |
0.945 | 181029 | 8 |
0.950 | 15535 | 4 |
Last trade - 15.24pm 10/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |